Skip to main content

ETH 383 Pill - orange oval, 13mm

Pill with imprint ETH 383 is Orange, Oval and has been identified as Carbidopa and Levodopa Extended Release 50 mg / 200 mg. It is supplied by Ethex Corporation.

Carbidopa/levodopa is used in the treatment of Parkinson's Disease; Neuroleptic Malignant Syndrome; GTP-CH Deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 50 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ETH 383

Carbidopa and levodopa extended release 50 mg / 200 mg ETH 383

Carbidopa and Levodopa Extended Release

ETH 383
50 mg / 200 mg
13.00 mm
Prescription only
Drug Class
Dopaminergic antiparkinsonism agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Ethex Corporation
National Drug Code (NDC)
58177-0383 (Discontinued)

Get help with Imprint Code FAQs.

Related images for "ETH 383"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.